Clinical Trials Logo

Clinical Trial Summary

Avoidant Restrictive Food Intake Disorder (ARFID) is a disorder that affects toddlers, children, adolescents, and adults. Individuals with ARFID are not able to consume an adequate amount or variety of food to a degree that it affects their mental and/or physical health. ARFID often begins in early childhood so it is important to treat children in early in life as possible to prevent any negative consequences of poor nutrition. There are currently no treatments for young children with ARFID. The investigators have developed two different study programs and the purpose of this study is to test them out and see if they help children with ARFID and to learn more about how these study programs work.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05105308
Study type Interventional
Source Duke University
Contact
Status Active, not recruiting
Phase N/A
Start date February 10, 2022
Completion date February 2025

See also
  Status Clinical Trial Phase
Terminated NCT03671551 - Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
Recruiting NCT05605067 - Genetic Architecture of Avoidant/Restrictive Food Intake Disorder